WallStreetZenWallStreetZen

NASDAQ: CRNX
Crinetics Pharmaceuticals Inc Stock Ownership - Who owns Crinetics Pharmaceuticals?

Insider buying vs selling

Have Crinetics Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Richard Scott StruthersPresident CEO2024-04-0440,951$49.17
$2.01MSell
Richard Scott StruthersPresident CEO2024-04-0440,951$9.28
$380.03kBuy
Stephanie OkeyDirector2024-03-2817,500$18.29
$320.08kBuy
Stephanie OkeyDirector2024-03-2817,500$46.38
$811.65kSell
Jeff E. KnightChief Operating Officer2024-03-2230,000$23.98
$719.40kBuy
Jeff E. KnightChief Operating Officer2024-03-2230,000$44.22
$1.33MSell
Jeff E. KnightChief Operating Officer2024-03-222,359$45.39
$107.08kSell
Matthew K. FustDirector2024-03-2017,500$18.29
$320.08kBuy
Matthew K. FustDirector2024-03-2012,500$43.57
$544.63kSell
Matthew K. FustDirector2024-03-2012,500$43.57
$544.63kSell

1 of 6

CRNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRNX insiders and whales buy or sell their stock.

CRNX Shareholders

What type of owners hold Crinetics Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC11.36%7,908,985$352.66MInsider
Blackrock Inc7.68%5,345,114$238.34MInstitution
Driehaus Capital Management LLC7.24%5,039,957$224.73MInstitution
Fmr LLC5.81%4,043,865$180.32MInstitution
State Street Corp5.12%3,563,736$158.91MInstitution
Vanguard Group Inc5.03%3,502,452$156.17MInstitution
Point72 Asset Management LP4.91%3,416,900$152.36MInstitution
Wellington Management Group LLP4.66%3,245,105$144.70MInstitution
Price T Rowe Associates Inc4.32%3,008,858$134.16MInstitution
Jennison Associates LLC3.66%2,547,683$113.60MInstitution

1 of 3

CRNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRNX85.02%14.98%Net SellingNet Selling
ACLX44.19%55.81%Net SellingNet Selling
IDYA88.70%10.03%Net SellingNet Selling
ARWR62.55%10.70%Net SellingNet Selling
XENE95.45%3.29%Net SellingNet Selling

Crinetics Pharmaceuticals Stock Ownership FAQ

Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals (NASDAQ: CRNX) is owned by 101.52% institutional shareholders, 17.88% Crinetics Pharmaceuticals insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Crinetics Pharmaceuticals shareholder, owning 7.91M shares representing 11.36% of the company. Perceptive Advisors LLC's Crinetics Pharmaceuticals shares are currently valued at $345.46M.

If you're new to stock investing, here's how to buy Crinetics Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.